Atsushi Horiike

Japanese Foundation For Cancer Research ORCID: 0000-0002-1632-3125

2

h-index

2

Publications

3,182

Citations

Publications

2 shown

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok , Yi‐Long Wu , Iveta Kudaba +97 more

2019 The Lancet 3175 citations

Serum Heparan Sulfate Concentration is Correlated with the Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients with Lung Adenocarcinoma

Makoto Nishio , Takeharu Yamanaka , Kazuko Matsumoto +12 more

2011 Journal of Thoracic Oncology 7 citations

Frequent Co-Authors

Tony Mok

Chinese University of Hong Kong

Yi‐Long Wu

Guangdong Provincial People's Hospital

Iveta Kudaba

Riga East University Hospital

Dariusz M. Kowalski

Université Toulouse III - Paul Sabatier

Byoung Chul Cho

Yonsei University

H.Z. Turna

Istanbul University

Researcher Info

h-index: 2
Publications: 2
Citations: 3,182
Institution: Japanese Foundation For Cancer Research

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-1632-3125

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.